Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

PTPI Relative to the S&P 500

PTPI Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Petros Pharmaceuticals Inc. (NASD:PTPI) seasonal charts above shows that a Buy Date of November 20 and a Sell Date of February 27 has resulted in a geometric average return of 56.17% above the benchmark rate of the S&P 500 Total Return Index over the past 13 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 13 years by an average of 59.27% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Petros Pharmaceuticals Inc is a men’s health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function.?The company’s operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.

To download PTPI seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: PTPI